Glioma cells treated with curcumin reduced the expression of HSP60 and likely its release and interaction with TLR-4, hindering the activation of the downstream pro-inflammatory pathway, mediated by MYD88 and NF-κB. The gene discussed is TLR4; the disease is glioma.